• J Kulisevsky, M R Luquin, J M Arbelo, J A Burguera, F Carrillo, A Castro, J Chacón, P J García-Ruiz, E Lezcano, P Mir, J C Martinez-Castrillo, I Martínez-Torres, V Puente, A Sesar, F Valldeoriola-Serra, and R Yañez.
• Servicio de Neurologia, Hospital Sant Pau, Barcelona, España. Electronic address: JKulisevsky@santpau.cat.
• Neurologia. 2013 Nov 1; 28 (9): 558-83.

IntroductionMany patients who have had Parkinson's disease (PD) for several years will present severe motor fluctuations and dyskinesias which require more aggressive therapies. The different approaches which are now available include deep brain stimulation of the subthalamic nucleus or medial globus pallidus, subcutaneous infusion of apomorphine, and intestinal infusion of levodopa-carbidopa.ObjectiveTo define the indications and results for the 3 available therapies for advanced PD.DevelopmentExhaustive review of the literature concerning the indications and results of deep brain stimulation, subcutaneous apomorphine infusion and duodenal infusion of levodopa/carbidopa gel to treat patients with advanced Parkinson disease.ConclusionsAlthough numerous studies have confirmed the efficacy of the 3 different therapies in advanced PD, there are no comparative studies that would allow us to define the best candidate for each technique.Copyright © 2013 Sociedad Española de Neurología. Published by Elsevier Espana. All rights reserved.

27 keywords...

hide…